Overview

Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This study is being done to see whether dietary and medicinal measures compliant with hyperlipidemia treatment guidelines will result in achieving target lipid values and to evaluate the total risk of cardiovascular disease in study participants who have not reached satisfactory lipid levels with their current hypolipemic therapy.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.